SeQuent to acquire 51% of Indo Phyto

0
1755
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

SeQuent Scientific has announced that it will acquire a controlling stake in Indo Phyto Chemicals (IPC), a New Delhi-based pharmaceutical company that focuses on female healthcare.

Chemical_structure,_vitamin_DIPC has a portfolio of steroids and hormonal active pharmaceutical ingredients (APIs) along with a manufacturing base in Uttarakhand. The company has capabilities in fermentation and chemical synthesis, giving it the ability to produce APIs from the basic starting materials that are extracted from plants. IPC currently produces 14 APIs and has 20 more under development.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link